Hate ads?! Want to be able to search and filter? Day and Night mode? Subscribe for just $5 a month!

Exclusive — Sen. Jim Banks: COVID Proved U.S. Must Bring Drug Manufacturing Back from China

Listen to Article

Sen. Jim Banks (R-IN) just dropped a bombshell at a Breitbart News policy event, declaring that the COVID-19 pandemic exposed America’s Achilles’ heel: our dangerous overreliance on China for critical drug manufacturing. The coronavirus pandemic proved the urgency with which the United States needs to bring drug manufacturing back from China, Banks stated flatly, highlighting how supply chain chokepoints left us scrambling for basics like antibiotics, painkillers, and even insulin during the crisis. This isn’t just economic nationalism—it’s a wake-up call rooted in hard lessons from 2020, when Beijing’s export restrictions on pharmaceuticals turned a health emergency into a geopolitical weapon. Banks is spot-on: 80-90% of our active pharmaceutical ingredients come from China or India (with heavy Chinese influence), per FDA data, making us vassals to a regime that’s no friend to American sovereignty.

For the 2A community, this hits closer to home than you might think. Reshoring drug production isn’t merely about pills—it’s about securing the medical backbone that keeps patriots in the fight. Imagine black swan events like pandemics, EMP attacks, or civil unrest spiking demand for trauma meds, antibiotics for wound infections, or pain management post-shooting. Our self-defense ethos demands readiness, yet we’re one Xi Jinping sneeze away from empty shelves. Banks’ push aligns perfectly with 2A resilience: just as we stockpile ammo and train for self-reliance, bringing manufacturing home fortifies the homefront against foreign dependency. It’s no coincidence that pro-2A states like Indiana (Banks’ turf) lead in manufacturing revival—think Cerakote finishes, polymer frames, and now potentially life-saving meds made on American soil.

The implications ripple outward: expect legislative momentum with bills like the CHIPS Act’s pharma cousins gaining traction, pressuring Big Pharma to onshore or face tariffs. For gun owners, this means advocating for supply chain security as a national security issue—pair it with 2A protections to ensure no federal overreach stifles domestic production. Banks isn’t whistling Dixie; COVID was the preview, and ignoring it invites disaster. Time to rally: contact your reps, support reshoring initiatives, and keep that med kit stocked. America’s independence—medical and martial—depends on it.

Share this story